Publications by authors named "Guangjun Jing"

Claim this Profile
I
Improved biodistribution and antitumor effects of a Nectin4 and Trop2 bispecific fatty acid-modified nanobody conjugate.
Guangjun Jing, Jiajun Fan, Xuyao Zhang, Xian Zeng, Zheng Song

J Control Release· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DDR1 Drives Collagen Remodeling and Immune Exclusion: Pan-Cancer Insights and Therapeutic Targeting in Pancreatic Ductal Adenocarcinoma.
Xuan Huang, Guangjun Jing, Kudelaidi Kuerban, Jiajun Fan, Mei Yu

Int J Mol Sci· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of CD33-targeted CAR-NK cell therapy for relapsed/refractory AML: preclinical evaluation and phase I trial.
Ruihao Huang, Xiaoqi Wang, Hongju Yan, Xu Tan, Yingying Ma, Guangjun Jing

Exp Hematol Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simultaneous blockade of VEGF-B and IL-17A ameliorated diabetic kidney disease by reducing ectopic lipid deposition and alleviating inflammation response.
Zhonglian Cao, Hui Zhao, Jiajun Fan, Yilan Shen, Lei Han, Guangjun Jing

Cell Death Discov· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Follow-Up of Combination of B-Cell Maturation Antigen and CD19 Chimeric Antigen Receptor T Cells in Multiple Myeloma.
Ying Wang, Jiang Cao, Weiying Gu, Ming Shi, Jianping Lan, Guangjun Jing

J Clin Oncol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of a humanized CD19 chimeric antigen receptor T cells for relapsed/refractory acute lymphoblastic leukemia.
Ming Shi, Li Li, Shiyuan Wang, Hai Cheng, Wei Chen, Guangjun Jing

Am J Hematol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel nanobody-heavy chain antibody against Angiopoietin-like protein 3 reduces plasma lipids and relieves nonalcoholic fatty liver disease.
Xiaozhi Hu, Jiajun Fan, Qianqian Ma, Lei Han, Zhonglian Cao, Jingyun Luan, Guangjun Jing

J Nanobiotechnology· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Humoral immune reconstitution after anti-BCMA CAR T-cell therapy in relapsed/refractory multiple myeloma.
Ying Wang, Chunrui Li, Jieyun Xia, Ping Li, Jiang Cao, Guangjun Jing

Blood Adv· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Humanized CD19-targeted chimeric antigen receptor T (CAR-T) cells for relapsed/refractory pediatric acute lymphoblastic leukemia.
Shiyuan Wang, Xue Wang, Chunying Ye, Hai Cheng, Ming Shi, Guangjun Jing

Am J Hematol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kinetics of immune reconstitution after anti-CD19 chimeric antigen receptor T cell therapy in relapsed or refractory acute lymphoblastic leukemia patients.
Ying Wang, Hujun Li, Xuguang Song, Kunming Qi, Hai Cheng, Guangjun Jing

Int J Lab Hematol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Immunoglobulin D Multiple Myeloma.
Wei Chen, Ying Wang, Kunming Qi, Ming Shi, Jiang Cao, Guangjun Jing

Transplant Cell Ther· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of chimeric antigen receptor T-cell therapy in relapsed/refractory multiple myeloma with renal impairment.
Hujun Li, Lingling Yin, Ying Wang, Xiangmin Wang, Ming Shi, Guangjun Jing

Bone Marrow Transplant· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of chimeric antigen receptor (CAR)-T-cell therapy in persons with advanced B-cell cancers and hepatitis B virus-infection.
Ying Wang, Yang Liu, Xu Tan, Bin Pan, Jian Ge, Guangjun Jing

Leukemia· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coagulation Disorders after Chimeric Antigen Receptor T Cell Therapy: Analysis of 100 Patients with Relapsed and Refractory Hematologic Malignancies.
Ying Wang, Kunming Qi, Hai Cheng, Jiang Cao, Ming Shi, Guangjun Jing

Biol Blood Marrow Transplant· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Humanized CD19-specific chimeric antigen-receptor T-cells in 2 adults with newly diagnosed B-cell acute lymphoblastic leukemia.
Jiang Cao, Hai Cheng, Ming Shi, Gang Wang, Wei Chen, Jing Zhao, Guangjun Jing

Leukemia· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A combination of humanised anti-CD19 and anti-BCMA CAR T cells in patients with relapsed or refractory multiple myeloma: a single-arm, phase 2 trial.
Zhiling Yan, Jiang Cao, Hai Cheng, Jianlin Qiao, Huanxin Zhang, Guangjun Jing, Jing Zhao

Lancet Haematol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Antibody Fab Fragment-based Chimeric Antigen Receptor Could Efficiently Eliminate Human Thyroid Cancer Cells.
Honghong Duan, Huibin Huang, Guangjun Jing

J Cancer· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potent anti-leukemia activities of humanized CD19-targeted Chimeric antigen receptor T (CAR-T) cells in patients with relapsed/refractory acute lymphoblastic leukemia.
Jiang Cao, Gang Wang, Hai Cheng, Chen Wei, Kunming Qi, Jing Zhao, Guangjun Jing

Am J Hematol· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erp29 Attenuates Cigarette Smoke Extract-Induced Endoplasmic Reticulum Stress and Mitigates Tight Junction Damage in Retinal Pigment Epithelial Cells.
Chuangxin Huang, Joshua J Wang, Guangjun Jing, Junhua Li, Chenjin Jin

Invest Ophthalmol Vis Sci· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ATF4 is a novel regulator of MCP-1 in microvascular endothelial cells.
Huibin Huang, Guangjun Jing, Joshua J Wang, Nader Sheibani, Sarah X Zhang

J Inflamm (Lond)· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of p58IPK as a novel neuroprotective factor for retinal neurons.
Evgenii Boriushkin, Joshua J Wang, Junhua Li, Guangjun Jing, Gail M Seigel

Invest Ophthalmol Vis Sci· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulatory role of nucleophosmin during the differentiation of human liver cancer cells.
Dong-Hui Xu, Fan Liu, Xiao Li, Xiang-Feng Chen, Guang-Jun Jing

Int J Oncol· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ER stress and apoptosis: a new mechanism for retinal cell death.
Guangjun Jing, Joshua J Wang, Sarah X Zhang

Exp Diabetes Res· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The localization of hnRNP A2/B1 in nuclear matrix and the aberrant expression during the RA-induced differentiation of human neuroblastoma SK-N-SH cells.
Ying Liang, Song-Lin Shi, Qi-Fu Li, Lan-Ying Chen, Guang-Jun Jing

J Cell Biochem· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aberrant expression and localization of hnRNP-A2/B1 is a common event in human gastric adenocarcinoma.
Guang-Jun Jing, Dong-Hui Xu, Song-Lin Shi, Qi-Fu Li, San-Ying Wang

J Gastroenterol Hepatol· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis